DiaMedica Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) announced its participation in three investor conferences in March 2021. The conferences include the 33rd Annual Roth Conference on March 15, where management will engage in a fireside chat and 1-on-1 meetings. The Oppenheimer’s 31st Annual Healthcare Conference is scheduled for March 16, featuring a corporate presentation and 1-on-1 meetings. Lastly, the Maxim’s Emerging Growth Conference will take place on March 17, also including a corporate presentation and 1-on-1 meetings.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the company will participate in three upcoming investor conferences. Details of the company’s participation are as follows:

• 33^rd Annual Roth Conference
  Details: DiaMedica Therapeutics management will deliver a fireside chat and participate in 1-on-1 meetings
  Company conference participation date: March 15^th, 2021

• Oppenheimer’s 31^st Annual Healthcare Conference
  Details: DiaMedica Therapeutics management will deliver a corporate presentation and participate in 1-on-1 meetings
  Company conference participation date: March 16^th, 2021

• Maxim’s Emerging Growth Conference
  Details: DiaMedica Therapeutics management will deliver a corporate presentation and participate in 1-on-1 meetings
  Company conference participation date: March 17^th, 2021

For more information or to schedule a one-on-one meeting with management, please contact your conference representative.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, please visit www.diamedica.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005912/en/

FAQ

When is DiaMedica's participation in the Roth Conference?

DiaMedica Therapeutics will participate in the 33rd Annual Roth Conference on March 15, 2021.

What details are available about DiaMedica's participation in the Oppenheimer Conference?

During Oppenheimer’s 31st Annual Healthcare Conference on March 16, 2021, DiaMedica will deliver a corporate presentation and participate in 1-on-1 meetings.

What is the schedule for DiaMedica at Maxim's Emerging Growth Conference?

DiaMedica Therapeutics will present at Maxim’s Emerging Growth Conference on March 17, 2021, and will also conduct 1-on-1 meetings.

How can I schedule a meeting with DiaMedica management during the conferences?

To schedule a 1-on-1 meeting with DiaMedica management at the conferences, please contact your conference representative.